Change of Name

Recorded: 2006-07-03 Pages: 4

Assignor

SYN X PHARMA INC.

Executed: 2006-02-09

Assignee

NANOGEN POINT OF CARE INC.

1 MARMAC DRIVE, TORONTO, ONTARIO, M9W 1E7, CANADA

Covered Property (1)

Diagnosis and treatment of early pre-Type-1 diabetes utilizing glial fibrillary acidic protein

Application: 11/132,975 →

Publication: US 2005/0214874

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.